This retrospective study was carry out to asses the clinical outcome a series of 205 histologically proven squamous cell carcinomas of head and neck treated at the Plastic Surgery Units, Ferrara University, Italy in the period between January 2005 and December 2010. There were 64 (31.2%) females and 141 (68.8%) males, age ranged from 40 to 102 years with a mean value of 82 years (standard deviation ± 11 years). There were 127 (62%) T1 and 78 (38.7%) T2. Surgical technique was a resection and immediate suturing in 203 (99%) cases whereas resection plus graft was used in 2 (1.0%) patients. None had positive neck nodes (N0) and neck dissection was not performed. Histologically positive margins were detected in 34 (16.6%) cases and a second...
Head and neck squamous cell carcinoma of the (HNSCC) represents approximately 5% of malignant tumour...
Head and neck squamous cell carcinoma of the (HNSCC) represents approximately 5% of malignant tumour...
OBJECTIVE:The recommended treatment for cutaneous squamous cell cancer (CuSCC) of the head and neck ...
This retrospective study was carry out to asses the clinical outcome a series of 758 histologically ...
Background/purposeSupraomohyoid neck dissection (SOHND) is commonly used to treat oral squa-mous cel...
Supraomohyoid neck dissection (SOHND) is commonly used to treat oral squa-mous cell carcinoma (OSCC)...
Objective: To assess the impact of close or positive surgical margins on the outcome, and to determi...
Background. To evaluate the outcome after surgery and radiotherapy for extensive nodal disease in pa...
Background: Surgical management of head and neck cancer is undoubtedly challenging, and we would lik...
Background: Surgical management of head and neck cancer is undoubtedly challenging, and we would lik...
Head and neck squamous cell carcinoma of the (HNSCC) represents approximately 5\% of malignant tumou...
Head and neck squamous cell carcinoma of the (HNSCC) represents approximately 5\% of malignant tumou...
Oral squamous cell carcinoma (OSCC) is one of the rarest cancers worldwide. In Indonesia, the incide...
Introduction: Selective neck dissection in clinically node negative neck is considered to be the st...
The clinical outcome of the overall recurrence after SND and RND in the treatment of oral squamous c...
Head and neck squamous cell carcinoma of the (HNSCC) represents approximately 5% of malignant tumour...
Head and neck squamous cell carcinoma of the (HNSCC) represents approximately 5% of malignant tumour...
OBJECTIVE:The recommended treatment for cutaneous squamous cell cancer (CuSCC) of the head and neck ...
This retrospective study was carry out to asses the clinical outcome a series of 758 histologically ...
Background/purposeSupraomohyoid neck dissection (SOHND) is commonly used to treat oral squa-mous cel...
Supraomohyoid neck dissection (SOHND) is commonly used to treat oral squa-mous cell carcinoma (OSCC)...
Objective: To assess the impact of close or positive surgical margins on the outcome, and to determi...
Background. To evaluate the outcome after surgery and radiotherapy for extensive nodal disease in pa...
Background: Surgical management of head and neck cancer is undoubtedly challenging, and we would lik...
Background: Surgical management of head and neck cancer is undoubtedly challenging, and we would lik...
Head and neck squamous cell carcinoma of the (HNSCC) represents approximately 5\% of malignant tumou...
Head and neck squamous cell carcinoma of the (HNSCC) represents approximately 5\% of malignant tumou...
Oral squamous cell carcinoma (OSCC) is one of the rarest cancers worldwide. In Indonesia, the incide...
Introduction: Selective neck dissection in clinically node negative neck is considered to be the st...
The clinical outcome of the overall recurrence after SND and RND in the treatment of oral squamous c...
Head and neck squamous cell carcinoma of the (HNSCC) represents approximately 5% of malignant tumour...
Head and neck squamous cell carcinoma of the (HNSCC) represents approximately 5% of malignant tumour...
OBJECTIVE:The recommended treatment for cutaneous squamous cell cancer (CuSCC) of the head and neck ...